The invention aims to overcome defects in the prior art and adverse reaction caused by western medicine after chemoradiotherapy of cancer patients, and provides a traditional Chinese medicine composition for assisting rehabilitation after the chemoradiotherapy of cancer patients. The traditional Chinese medicine composition is prepared by repeated verification of clinical tests, and conforms to the traditional Chinese medicine theory. According to the traditional Chinese medicine composition, hedyotis diffusa, Chinese actinidia root, cicca arietina, aspongopus and trigone are used as monarch drugs to resist cancer and inhibit tumor diffusion and deterioration; liriope spicata, rhizoma kaempferiae, Chinese hawthorn leaf, radix polygonati officinalis, rice sprout and hippophae rhamnoides are used as ministerial drugs to nourish yin, generate body fluid, promote qi, warm middle, promote gastric digestion and improve food intake; pepper, ginger, inula flower, cortex albiziae, lentinula edodes and black sesame are used as auxiliary drugs to warm middle, stop pain, calm nerves, relieve depression, activate blood and eliminate carbuncle; prepared rehmannia root, radix glycyrrhizae, carrot, mulberry, spina date seed and codonopsis pilosula are used as adjuvant drugs to improve immunity, nourish blood, nourish yin, reinforce essence, benefit marrow, strengthen middle and tonify qi.